Semaglutide and Tirzepatide for slowing aging in adults with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if two newer weight-loss medications, semaglutide and tirzepatide, can help slow the aging process in adults with obesity. It compares the drugs to each other and to a placebo to see which might offer anti-aging benefits beyond weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a body mass index (BMI) of 30 or higher, meaning you have obesity.
- You have not taken any weight-loss medications (like Wegovy, Ozempic, Mounjaro, or metformin for weight loss) in the past 3 months.
- You do not have diabetes that requires medication.
- You have never had pancreatitis, bariatric surgery, or a serious stomach problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different weight-loss medications (semaglutide and tirzepatide) taken alongside exercise to help people with obesity. It aims to see which approach works better for weight loss and overall health.
This study tests a new combination of two medications to help older adults with obesity lose weight. It aims to see if adding LUM-201 to semaglutide improves weight loss compared to semaglutide alone.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests whether the medication tirzepatide (a drug used for diabetes and weight loss) can slow the biological aging process in adults aged 55 to 70 who have excess weight. You would take the medication as a weekly injection for a set period, and researchers will monitor changes in your body's health markers.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.
Hear when a new Adults With Simple Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.